Evidence map›Paper›PMID 41220754›Full record

ArticleJournal of gastrointestinal oncology2025

Deciphering the immunometabolic axis: a mendelian randomization study of a causal cascade network from immune cell phenotypes to metabolites in esophageal cancer.

Daying Gui, Jingxun Wu, Yi Feng, Simin Lu, Siyu Guo, Kai Wu, Zhengyang Yan, Hehui Wang, Hejing Sun, Shubin Wang and 2 more

Abstract read
In one paragraph

Article in Journal of gastrointestinal oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Daying Gui *Department of Medical Oncology, Peking University Shenzhen Hospital, Shenzhen, China.
Jingxun Wu *Department of Medical Oncology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Yi Feng *Department of Thoracic Surgery and Oncology, China State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Simin LuDepartment of Medical Oncology, Peking University Shenzhen Hospital, Shenzhen, China.
Siyu GuoDepartment of Medical Oncology, Peking University Shenzhen Hospital, Shenzhen, China.
Kai WuDepartment of Medical Oncology, Peking University Shenzhen Hospital, Shenzhen, China.
Zhengyang YanDepartment of Medical Oncology, Peking University Shenzhen Hospital, Shenzhen, China.
Hehui WangDepartment of Medical Oncology, Peking University Shenzhen Hospital, Shenzhen, China.
Hejing SunDepartment of Medical Oncology, Peking University Shenzhen Hospital, Shenzhen, China.
Shubin WangDepartment of Medical Oncology, Peking University Shenzhen Hospital, Shenzhen, China.
Wenhua LiangDepartment of Thoracic Surgery and Oncology, China State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Xuan WuDepartment of Medical Oncology, Peking University Shenzhen Hospital, Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The causal relationship between immune cell phenotypes and esophageal cancer (EC) has not yet been fully elucidated. Further, the potential mediating role of metabolites in the relationship between immune cell phenotypes and EC remains largely unexplored. This study investigated the genetic mechanisms underlying the effects of immune cells on EC, and examined the mediating effects of metabolites. Methods: This study adopted a bidirectional two-sample Mendelian randomization (MR) approach to assess the causal relationship between immune cell phenotypes and EC. A reverse MR analysis was performed to eliminate potential reverse causation bias. Additionally, a two-step MR analysis and multivariable Mendelian randomization (MVMR) analysis were conducted to investigate potential metabolite mediators between immune cells and EC. Results: First, the bidirectional two-sample univariable MR analysis revealed statistically significant causal associations between 22 immune cell phenotypes and EC. A subsequent MRMR analysis was conducted to evaluate the independent causal effects of these phenotypes on EC, and revealed persistent significant correlations for three specific subtypes: CD38 Conclusions: This study provides genetic evidence supporting the causal roles of specific immune cell phenotypes, particularly CD38

Indexed as

esophageal cancer (EC)Immune cell phenotypeMendelian randomization (MR)plasma lipidomeplasma metabolome

Identifiers

PMID41220754
PMCPMC12598335

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.